Medicare Compliance & Reimbursement - 2014 Issue 40
Reader Question: Avoid 90662 for Patients Under 65
Subscribe or sign in to view the full article.
Article Overview
This article addresses a billing question involving influenza vaccine reporting and age-based coverage issues. It is written for coding and billing professionals who need to understand the general circumstances that can affect payer acceptance of influenza vaccine claims, including MAC-related coverage considerations, appeals, and the distinction between standard and higher-antigen influenza vaccine products. The discussion also notes when a different influenza vaccine code may be more appropriate in routine younger-patient scenarios.
Why This Topic Matters
Influenza vaccine claims can be denied when payer coverage policies do not align with the product administered or the patient population. Understanding the general coding and coverage context helps practices reduce denials and respond appropriately when a claim is questioned.
Article Sections
-
Question
A reader asks about a denied influenza vaccine claim and why the payer raised an age-related issue.
-
Answer
The response discusses coverage context for influenza vaccine reporting, appeal considerations, and the general distinction between enhanced and standard influenza vaccine scenarios.
What You Will Learn
- How influenza vaccine reporting can intersect with payer coverage considerations
- What general factors may lead to denial of an influenza vaccine claim
- When an appeal may be relevant in a vaccine coverage dispute
- How the article frames the difference between enhanced and standard influenza vaccine reporting
Who Should Read This
- Medical coders
- Billing staff
- Revenue cycle professionals
- Physician office staff
- Compliance staff
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com